Hypofractionated stereotactic re-irradiation with pembrolizumab and bevacizumab in patients with recurrent high-grade gliomas: results from a phase I study.
Sahebjam S, Forsyth PA, Tran ND, Arrington JA, Macaulay R, Etame AB, Walko CM, Boyle T, Peguero EN, Jaglal M, Mokhtari S, Enderling H, Raghunand N, Gatewood T, Long W, Dzierzeski JL, Evernden B, Robinson T, Wicklund MC, Kim S, Thompson ZJ, Chen DT, Chinnaiyan P, Yu HM.
Sahebjam S, et al. Among authors: arrington ja.
Neuro Oncol. 2021 Apr 12;23(4):677-686. doi: 10.1093/neuonc/noaa260.
Neuro Oncol. 2021.
PMID: 33173935
Free PMC article.
Clinical Trial.